Roche Holding AG Akt-0.52% CHF230.9B ...

Twist Bioscience Corp (TWST) reports a 24% revenue increase and improved gross margins, while outlining strategic plans for future growth and profitability. Twist Bioscience (TWST) has been ...

Twist Bioscience Corp (NASDAQ:TWST) reported record revenue of $88.7 million for the first quarter of 2025, marking a 24% year-over-year increase. The company achieved a gross margin of 48.3% ...

Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $52.00. The company’s shares closed last Friday at $52.37.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Good day. Thank you for standing by. Welcome to Twist Bioscience's 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the ...

After hours: 7:58:47 p.m. EST ...

Twist Bioscience (TWST) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.75 per share a year ago. These figures ...